SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005831
Filing Date
2018-03-15
Accepted
2018-03-15 16:17:46
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cbay-10k_20171231.htm 10-K 2422106
2 EX-10.7 cbay-ex107_169.htm EX-10.7 83507
3 EX-10.19 cbay-ex1019_168.htm EX-10.19 128682
4 EX-10.20 cbay-ex1020_170.htm EX-10.20 7773
5 EX-23.1 cbay-ex231_9.htm EX-23.1 4867
6 EX-31.1 cbay-ex311_8.htm EX-31.1 15943
7 EX-31.2 cbay-ex312_7.htm EX-31.2 16070
8 EX-32.1 cbay-ex321_6.htm EX-32.1 11120
9 GRAPHIC g2018031519563468510108.jpg GRAPHIC 3633
  Complete submission text file 0001564590-18-005831.txt   9933287

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT cbay-20171231.xml EX-101.INS 2466538
11 XBRL TAXONOMY EXTENSION SCHEMA cbay-20171231.xsd EX-101.SCH 53990
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20171231_cal.xml EX-101.CAL 51659
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20171231_def.xml EX-101.DEF 212979
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20171231_lab.xml EX-101.LAB 458355
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20171231_pre.xml EX-101.PRE 359551
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 18692603
SIC: 2834 Pharmaceutical Preparations